Anew Medical Statistics
Total Valuation
Anew Medical has a market cap or net worth of $22.39 million. The enterprise value is $23.69 million.
| Market Cap | 22.39M |
| Enterprise Value | 23.69M |
Important Dates
The next estimated earnings date is Thursday, August 15, 2024, after market close.
| Earnings Date | Aug 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Anew Medical has 15.13 million shares outstanding. The number of shares has decreased by -40.41% in one year.
| Shares Outstanding | 15.13M |
| Shares Change (YoY) | -40.41% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 62.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02, with a Debt / Equity ratio of 3.70.
| Current Ratio | 0.02 |
| Quick Ratio | n/a |
| Debt / Equity | 3.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.40% |
| Return on Capital (ROIC) | -57.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.50M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -255,773 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -85.94% |
| 50-Day Moving Average | 4.39 |
| 200-Day Moving Average | 8.87 |
| Relative Strength Index (RSI) | 33.49 |
| Average Volume (20 Days) | 6,626,573 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -977,613 |
| Pretax Income | -2.76M |
| Net Income | -2.50M |
| EBITDA | -2.68M |
| EBIT | -2.68M |
| Earnings Per Share (EPS) | -$0.17 |
Balance Sheet
The company has $32,336 in cash and $1.33 million in debt, giving a net cash position of -$1.30 million or -$0.09 per share.
| Cash & Cash Equivalents | 32,336 |
| Total Debt | 1.33M |
| Net Cash | -1.30M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 360,013 |
| Book Value Per Share | 0.02 |
| Working Capital | -1.95M |
Cash Flow
In the last 12 months, operating cash flow was -$119,915 and capital expenditures $37,740, giving a free cash flow of -$82,175.
| Operating Cash Flow | -119,915 |
| Capital Expenditures | 37,740 |
| Free Cash Flow | -82,175 |
| FCF Per Share | -$0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Anew Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 40.41% |
| Shareholder Yield | 40.41% |
| Earnings Yield | -11.16% |
| FCF Yield | -0.37% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |